Thrombosis Calf Veins

Level of Risk Calf Vein Thrombosis (%) Symptomatic PE (%) Fatal PE (%) Prevention Strategies... 

First episode of VTE secondary to a transient (reversible) risk factor Warfarin 3 Recommendation applies to both proximal and calf vein thrombosis... 

Treatment for established venous thrombosis is initiated with unfractionated or low-molecular-weight heparin for the first 5-7 days, with an overlap with warfarin. Once therapeutic effects of warfarin have been established, therapy with warfarin is continued for a minimum of 3-6 months. Patients with recurrent disease or identifiable, nonreversible risk factors may be treated indefinitely. Small thrombi confined to the calf veins may be managed without anticoagulants if there is documentation over time that the thrombus is not extending. 

Resistance of activated protein C and deep calf vein thrombosis has been reported during controlled ovarian stimulation for in vitro fertilization (18). The thrombosis occurred on the eighth day of human menopausal gonadotropin use and before human chorionic gonadotropin was given. 

Clinical and US Anatomy 745 Anterolateral Leg 745 Posteromedial Leg 749 Leg Pathology 755 Anterolateral Leg 755. 1 Muscle Hernias 755. 2 Medial Tibial Stress Syndrome 757. 3 Compartment Syndromes 757. 4 Superficial Peroneal Neuropathy 759 Posteromedial Leg 759. 1 Tears of the Medial Head of the Gastrocnemius 759. 2 Plantaris Tendon Tears 765. 3 Calf Vein Thrombosis 767 A Phlebitis of the Calf Veins 768. 5 Sural Neuropathy 769 Leg Masses 769 References 771... 

Subcutaneous heparin is used prophylactically to prevent deep vein thrombosis. Symptoms of a DVT include calf edema, redness, warmth, and pain on... 

---